Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Remifentanil.

Paula Mason1

  • 1St. George's Hospital, UK.

Intensive & Critical Care Nursing
|January 16, 2003
PubMed
Summary
This summary is machine-generated.

Remifentanil, a synthetic opioid, is now approved for sedating and managing pain in ventilated intensive care unit (ICU) patients. This expands its use beyond general anesthesia, making it relevant for critical care settings.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extubation Reflectivity.

Journal of perioperative practice·2018
Same author

Extubation reflectivity.

Journal of perioperative practice·2008
Same author

Levosimendan.

Intensive & critical care nursing·2003
Same journal

The use of the modified Dutch worry criteria, combined with vital signs and early warning scores, to improve nurses' recognition and escalation of ward deteriorating patients: A prospective cross-sectional observation multi-method study.

Intensive & critical care nursing·2026
Same journal

An exploration of the use of safety huddles in ICUs across the United Kingdom - A cross-sectional national e-survey.

Intensive & critical care nursing·2026
Same journal

Research integrity throughout the research lifecycle and stakeholders: Part 3 - From data analysis to post-publication.

Intensive & critical care nursing·2026
Same journal

Physical function at ICU discharge: A marker of risk or a target for intervention?

Intensive & critical care nursing·2026
Same journal

Competence is not enough: organisational readiness for safe ECMO nursing care.

Intensive & critical care nursing·2026
Same journal

Alarms and alarm management with automated versus conventional ventilation in neurocritical care patients.

Intensive & critical care nursing·2026
See all related articles

Area of Science:

  • Anesthesiology and Critical Care Medicine

Background:

  • Remifentanil is a potent synthetic opioid receptor agonist.
  • Initially approved in 1997 for intraoperative analgesia during general anesthesia.

Purpose of the Study:

  • To highlight the expanded clinical application of remifentanil.
  • To inform intensive care professionals about its new indication for ventilated patients.

Main Methods:

  • Review of recent licensing and clinical guidelines.
  • Analysis of pharmacological properties relevant to intensive care.

Main Results:

  • Remifentanil has recently gained approval for analgesia and sedation in mechanically ventilated intensive care patients.
  • This represents a significant expansion of its therapeutic use.

Conclusions:

  • Remifentanil is now a viable option for managing pain and sedation in the ICU.
  • Healthcare providers in intensive care should be aware of this updated indication.